ACM

at acm biolabs, we are focused on developing novel vaccines and antibodies using our proprietary artificial cell membrane ("acm"​) technology. we are able to incorporate functional, folded membrane proteins into the artificial cell membranes which keep them stable, allowing them to induce a strong immune reaction. we have demonstratedefficacy via both injected and oral dosages using synthesized membrane proteins and have a growing pipeline of vaccine and antibodies.the company is headquartered in singapore, and has been operational since 2013.